Transient atrial mechanical dysfunction (stunning) after cardioversion of atrial fibrillation and flutter

American Heart Journal

Volumn 144, Issue 1, 2002, Pages 11-22

  Khan, Ijaz A ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSTROPHANTHIDIN; DOFETILIDE; SOTALOL; VERAPAMIL;

A WAVE; ANTICOAGULATION; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVERSION; DRUG EFFECT; ECHOCARDIOGRAPHY; ELECTRIC CURRENT; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; MYOCARDIAL HIBERNATION; PRIORITY JOURNAL; RISK ASSESSMENT; SINUS RHYTHM; STROKE; STUNNED HEART MUSCLE;

EID: 0036302215     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.123113     Document Type: Article

References (80)

1. Epidemiology and natural history of atrial fibrillation: Clinical implications
2. Heart rate control in patients with atrial fibrillation
3. Acute ventricular rate control in atrial fibrillation: IV combination of diltiazem and digoxin vs IV diltiazem alone
4. Atrial fibrillation: Problems in management
5. Embolic stroke after unanticoagulated cardioversion despite prior exclusion of atrial thrombi by transoesophageal echocardiography
6. Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation
7. Exclusion of atrial thrambus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation: A multicenter study
8. Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm
9. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation
10. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneaus echo contrast: Characterization by simultaneous transesophageal echocardiography
11. Delayed restoration of atrial function after conversion of atrial flutter by pacing or electrical cardioversion
12. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: Evidence for atrial stunning as a mechanism of thromboembolic complications
13. Impaired left atrial mechanical function after cardioversion: Relation to the duration of atrial fibrillation
14. Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm
15. Left atrial appendage stunning after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography
16. Transesophageal echocardiographic evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioversion of atrial fibrillation
17. Restoration of atrial function after atrial fibrillation of different etiological origins
18. Evaluation of left atrial appendage function by measurement of changes in flow velocity patterns after electrical cardioversion in patients with isolated atrial fibrillation
19. Left atrial chamber and appendage function after internal atrial defibrillation: A prospective and serial transesophageal echocardiographic study
20. Clinical variables affecting recovery of left atrial mechanical function after cardioversion from atrial fibrillation
21. Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter. A prospective study using transesophageal echocardiography
22. Left atrial appendage stunning after electrical cardioversion of atrial flutter: An attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events
23. Stunning of the left atrium after spontaneous conversion of atrial fibrillation to sinus rhythm: Demonstration by transesophageal Doppler techniques in a canine model
24. Mechanical dysfunction of the left atrium and the left atrial appendage following cardioversion of atrial fibrillation and its relation to total electrical energy used for cardioversion
25. Left atrial appendage function assessed by transesophageal echocardiography before and on the day after elective cardioversion for nonvalvular atrial fibrillation
26. Left atrial stunning following radiofrequency catheter ablation of chronic atrial flutter
27. Acute changes in spontaneous echo contrast and atrial function after cardioversion of persistent atrial flutter
28. Impairment of left atrial appendage function after spontaneous conversion of atrial flutter
29. Idiopathic atrial fibrillation of recent onset and atrial stunning: The echocardiographic evidence after pharmacological cardioversion
30. Atrial stunning and pharmacologic cardioversion in idiopathic atrial fibrillation of recent onset
31. Atrial ejection force in patients with atrial fibrillation: Comparison between DC shock and pharmacological cardioversion
32. Transesophageal echocardiographic evidence of more pronounced left atrial stunning after chemical (propafenone) rather than electrical attempts at cardioversion from atrial fibrillation
33. Left atrial mechanical function after brief duration atrial fibrillation
34. Short-term effect of atrial fibrillation on atrial contractile function in humans
35. Serial evaluation of left atrial dimension after cardioversion for atrial fibrillation and relation to atrial function
36. Effects of cardiac glycosides on atrial contractile dysfunction after short-term atrial fibrillation
37. Right atrial thrombi and depressed right atrial appendage function after cardioversion of atrial fibrillation
38. Left atrial activity following cardioversion
39. Left atrial function after electrical conversion to sinus rhythm
40. Atrial contractile performance after cessation of atrial fibrillation
41. Echographic assessment of atrial transport, mitral movement, and ventricular performance following electroversion of supraventricular arrhythmias
42. Cyclic changes of blood echogenicity in high-frequency ultrasound
43. Echocardiographic smoke is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces
44. Prevalence and clinical implications of atrial spontaneous contrast in patients undergoing transesophageal echocardiography
45. Left atrial spontaneous contrast echoes: Markers of thromboembolic risk in patients with atrial fibrillation
46. Left atrial spontaneous echo contrast: A clinical and echocardiographic analysis
47. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo
48. Left atrial appendage blood flow determined by transesophageal echocardiography in healthy subjects
49. Influence of aging on left atrial appendage flow velocity patterns in normal subjects
50. Pulsed Doppler characterization of left atrial appendage flow
51. Clinical implications of left atrial appendage function: Its influence on thrombus formation
52. Patterns of Doppler-measured blood flow velocity in the normal and fibrillating human left atrial appendage
53. Left atrial appendage Doppler flow patterns: Implications on thrombus formation
54. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation
55. Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic otrial fibrillation: Identification of a subgroup of patients at increased embolic risk
56. Echocardiographic assessment of the left atrial appendage
57. Effect of direct current shocks on left atrial mechanical function in patients with structural heart disease
58. Evaluation of the effect of transthoracic cardioversion from ventricular tachycardia to sinus rhythm on left atrial mechanical function
59. Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: A transesophageal echocardiographic study
60. Left atrial appendage function in patients with atrial flutter
61. Right atrial appendage thrombosis in atrial fibrillation: Its frequency and its clinical predictors
62. Further experience of electrical cardioversion of atrial fibrillation to sinus rhythm: Analysis of 100 patients
63. Cardioversion of atrial fibrillation of recent onset with flecainide
64. Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation
65. Metabolic changes and mitochondrial dysfunction early following transthoracic countershock in dogs
66. Direct effects of DC cardioversion on blood echogenicity: An in vitro study
67. Atrial fibrillation: A tachycardia-induced atrial cardiomyopathy
68. Electrical remodeling in atrial fibrillation: Time course and mechanisms
69. Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia
70. Contractile dysfunction and ATP depletion after transient calcium overload in perfused ferret hearts
71. Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644
72. Cytosolic calcium staircase in cultured myocardial cells
73. Dedifferentiation of atrial cardiomyocytes as a result of chronic atrial fibrillation
74. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat
75. Structural remodeling of atrial myocardium in patients with cardiac valve disease and atrial fibrillation
76. The relationship of human atrial cellular electrophysiology to clinical function and ultrastructure
77. Aggravation of postcardioversion atrial dysfunction by sotalol
78. Hemodynamic performances in patients treated with sotalol after electrical cardioversion of atrial fibrillation
79. Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutter
80. Comparative hemodynamic effects of amiodarone, sotalol, and d-sotalol